-
Roscovitine: CDK Timing in Tumor Immunology
2026-08-13
Roscovitine (Seliciclib) is a reversible CDK inhibitor that helps separate tumor-cell cycle effects from immune-mediated responses. This article develops an assay-centered framework linking CDK biology with radiotherapy and checkpoint-blockade research without overclaiming combination efficacy.
-
BX795: PDK1 Inhibitor Workflows for Cancer & Immunity
2026-08-13
BX795 supports a single-molecule strategy for dissecting PDK1-driven AKT signaling alongside TBK1–IRF3 innate immune responses. This practical guide connects biochemical assays, cancer cell growth inhibition, and HBV-related immune-evasion studies with assay-ready optimization and troubleshooting advice.
-
Nigericin Workflows for pH and Ion Transport
2026-08-12
Nigericin provides a practical way to perturb potassium/proton exchange while tracking intracellular pH, mitochondrial behavior, and GSDMD-associated death phenotypes. This workflow-focused guide also shows how metabolic findings from antibiotic-resistance research can improve assay design without overstating cross-domain evidence.
-
Cimetidine in BBB and GI Cancer Research
2026-08-12
Cimetidine supports parallel investigation of H2 receptor biology, gastric acid secretion inhibition, and barrier transport in translational assays. This workflow pairs practical formulation guidance with the high-throughput BBB strategy reported in a 2025 surrogate-barrier study, while clearly separating validated findings from optimization recommendations.
-
Nitrocefin Assays: From Color Change to Mechanism
2026-08-11
Nitrocefin is a chromogenic cephalosporin substrate that makes β-lactamase activity visible. This guide connects its yellow-to-red signal with enzyme specificity, assay controls, and resistance-mechanism interpretation using recent GOB-38 research.
-
Anlotinib hydrochloride for Angiogenesis Assays
2026-08-11
Build a mechanism-centered angiogenesis workflow around Anlotinib hydrochloride, from endothelial migration and tube formation to receptor phosphorylation. This guide combines nanomolar target data with practical dosing, controls, troubleshooting, and orthogonal validation strategies for cancer research.
-
Multianimal MRI for Pancreatic Tumor Monitoring
2026-08-10
Kempinska et al. describe a four-chamber MRI workflow that images up to four KPC mice in one high-resolution acquisition, reducing the time and cost of longitudinal pancreatic tumor assessment. The protocol also provides a practical imaging framework for evaluating treatment response, demonstrated through a proof-of-concept study of gemcitabine in a clinically relevant pancreatic ductal adenocarcinoma model.
-
Temozolomide Beyond the Standard Glioma Model
2026-08-09
Temozolomide is more than a routine cytotoxic control: it is a mechanistically informative DNA damage probe for biomarker-stratified glioma research. This thought-leadership guide connects its methylation chemistry with ATRX-dependent vulnerability, experimental design, combination strategy, and translational interpretation.
-
WAY-100635 in Serotonin-Pain Assay Design
2026-08-08
WAY-100635 enables precise 5-HT1A receptor dissection in pain and affect research. This guide develops an assay-centered framework linking antagonist pharmacology with cannabidiol studies, behavioral readouts, circuit measurements, and receptor imaging.
-
GOB-38 in Elizabethkingia: Activity and Substrate Scope
2026-08-07
The reference study characterizes GOB-38, a B3-Q metallo-β-lactamase from Elizabethkingia anophelis, combining recombinant enzyme biochemistry with genomic and co-culture analyses. Its broad hydrolysis profile and potential contribution to carbapenem resistance clarify why substrate-specific β-lactamase testing is important in resistance research.
-
Optimizing Cell Assays with 2'3'-cGAMP (sodium salt) SKU B83
2026-08-07
This article offers practical, scenario-driven guidance for leveraging 2'3'-cGAMP (sodium salt) (SKU B8362) in cell viability, proliferation, and cytotoxicity assays. With insights into assay reproducibility, signaling specificity, and product reliability, it showcases evidence-backed protocols and addresses common lab workflow challenges.
-
PA-824: Strategic Innovations in Tuberculosis Drug Discovery
2026-08-06
This thought-leadership article explores the multifaceted mechanism of PA-824, a bicyclic nitroimidazole derivative, and advances strategic guidance for translational tuberculosis researchers. Integrating recent mechanistic insights, competitive dynamics, and new synergy-driven protocols, it positions PA-824 not only as a research compound but as a catalyst for next-generation drug regimens. The discussion is anchored by recent research on terminal oxidase inhibition and augmented by workflow best practices, explicitly distinguishing this resource from conventional product literature.
-
Quercetin Suppresses Neuroinflammation in LPS-Induced Depres
2026-08-06
This study demonstrates that quercetin, a dietary PI3K inhibitor, alleviates depressive-like behaviors and cognitive deficits in an LPS-induced mouse model by suppressing NLRP3 inflammasome activation and neuroinflammatory cytokine production. These findings highlight quercetin's mechanistic potential as a research tool for investigating inflammation-driven depression and cognitive impairment.
-
Dacarbazine: Antineoplastic Chemotherapy Drug in Modern Canc
2026-08-05
Dacarbazine stands out as a cornerstone antineoplastic chemotherapy drug, but its true research value emerges with precise, protocol-driven applications. This article unpacks optimized workflows, in vitro response metrics, and troubleshooting strategies that leverage Dacarbazine for advanced cancer research.
-
PA-824: Bicyclic Nitroimidazole Derivative in TB Research Wo
2026-08-05
PA-824, a potent bicyclic nitroimidazole derivative, delivers dual-action efficacy against both replicating and drug-resistant Mycobacterium tuberculosis. This guide details advanced workflow strategies, protocol parameters, and troubleshooting solutions to maximize the impact of PA-824 in tuberculosis research.